Literature DB >> 16436618

Synaptic vesicle protein 2 enhances release probability at quiescent synapses.

Kenneth L Custer1, Naola S Austin, Jane M Sullivan, Sandra M Bajjalieh.   

Abstract

We report a thorough analysis of neurotransmission in cultured hippocampal neurons lacking synaptic vesicle protein 2 (SV2), a membrane glycoprotein present in all vesicles that undergo regulated secretion. We found that SV2 selectively enhances low-frequency neurotransmission by priming morphologically docked vesicles. Loss of SV2 reduced initial release probability during a train of action potentials but had no effect on steady-state responses. The amount and decay rate of asynchronous release, two measures sensitive to presynaptic calcium concentrations, are not altered in SV2 knock-outs, suggesting that SV2 does not act by modulating presynaptic calcium. Normal neurotransmission could be temporarily recovered by delivering an exhaustive stimulus train. Our results indicate that SV2 primes vesicles in quiescent neurons and that SV2 function can be bypassed by an activity-dependent priming mechanism. We propose that SV2 action modulates synaptic networks by ensuring that low-frequency neurotransmission is faithfully conveyed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436618      PMCID: PMC6674579          DOI: 10.1523/JNEUROSCI.2699-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface.

Authors:  Y J Son; T W Scranton; W J Sunderland; S J Baek; J H Miner; J R Sanes; S S Carlson
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

2.  Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity.

Authors:  T Xu; T Binz; H Niemann; E Neher
Journal:  Nat Neurosci       Date:  1998-07       Impact factor: 24.884

3.  Complexins regulate a late step in Ca2+-dependent neurotransmitter release.

Authors:  K Reim; M Mansour; F Varoqueaux; H T McMahon; T C Südhof; N Brose; C Rosenmund
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

4.  Synaptotagmin I functions as a calcium regulator of release probability.

Authors:  R Fernández-Chacón; A Königstorfer; S H Gerber; J García; M F Matos; C F Stevens; N Brose; J Rizo; C Rosenmund; T C Südhof
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

5.  SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.

Authors:  R Janz; Y Goda; M Geppert; M Missler; T C Südhof
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

6.  Inhibition of SNARE complex assembly differentially affects kinetic components of exocytosis.

Authors:  T Xu; B Rammner; M Margittai; A R Artalejo; E Neher; R Jahn
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

7.  Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).

Authors:  K M Crowder; J M Gunther; T A Jones; B D Hale; H Z Zhang; M R Peterson; R H Scheller; C Chavkin; S M Bajjalieh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles.

Authors:  I Augustin; C Rosenmund; T C Südhof; N Brose
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

9.  SV2 modulates the size of the readily releasable pool of secretory vesicles.

Authors:  T Xu; S M Bajjalieh
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

10.  Properties of synchronous and asynchronous release during pulse train depression in cultured hippocampal neurons.

Authors:  D J Hagler; Y Goda
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

View more
  71 in total

Review 1.  Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

Authors:  Juan Luis Becerra; Joaquín Ojeda; Enrique Corredera; Jesús Ruiz Giménez
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

2.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

3.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 4.  Kinetics of synaptic transmission at ribbon synapses of rods and cones.

Authors:  Wallace B Thoreson
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

5.  How ready can a synaptic vesicle be? SV2 may have the answer.

Authors:  Gregory C Mathews
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

6.  The habenular G-protein-coupled receptor 151 regulates synaptic plasticity and nicotine intake.

Authors:  Beatriz Antolin-Fontes; Kun Li; Jessica L Ables; Michael H Riad; Andreas Görlich; Maya Williams; Cuidong Wang; Sylvia M Lipford; Maria Dao; Jianxi Liu; Henrik Molina; Nathaniel Heintz; Paul J Kenny; Ines Ibañez-Tallon
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-25       Impact factor: 11.205

7.  Expression of genes encoding multi-transmembrane proteins in specific primate taste cell populations.

Authors:  Bryan D Moyer; Peter Hevezi; Na Gao; Min Lu; Dalia Kalabat; Hortensia Soto; Fernando Echeverri; Bianca Laita; Shaoyang Anthony Yeh; Mark Zoller; Albert Zlotnik
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

8.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  Large structural change in isolated synaptic vesicles upon loading with neurotransmitter.

Authors:  Kristi L Budzinski; Richard W Allen; Bryant S Fujimoto; P Kensel-Hammes; David M Belnap; Sandra M Bajjalieh; Daniel T Chiu
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

10.  Loss of the Synaptic Vesicle Protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina.

Authors:  Catherine W Morgans; Patricia Kensel-Hammes; James B Hurley; Kimberly Burton; Rejean Idzerda; G Stanley McKnight; Sandra M Bajjalieh
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.